Ataxin-3 has been shown to deubiquitinate and therefore stabilise KLF4, and it is hypothesised that the up-regulation of ATXN3 observed in breast cancer contributes to up-regulation of KLF4, thereby accelerating breast cancer metastasis [21]. Here, ATXN3 is linked to breast carcinoma.